WOONSOCKET, R.I., May 15, 2017 /PRNewswire/ — Launching this month from CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), is the new multi-platform Long Live Skin campaign aimed at increasing awareness around skin health, sun safety and the importance of proper skincare. The Long Live Skin Campaign kicks off today on https://www.cvs.com/longliveskin and […]

WOONSOCKET, R.I., May 11, 2017 /PRNewswire/ — Drawing some of the biggest names in golf to the greens of the Rhode Island Country Club, the CVS Health Charity Classic has expanded this year’s event series for golf fans and non-golf fans alike. This year’s Charity Classic event series will kick off with Crave RI, a […]

After Finding Too Much “Dirt” on Kellan Lutz During His Audition to Be #TheNextMrClean, the Mr. Announces Open Casting Call and $20,000 Prize CINCINNATI–September 8, 2016–(BUSINESS WIRE)–After nearly 60 years of being tough on dirt all around the house, Mr. Clean announced today that he will be taking a much-deserved extended vacation. However, before he […]

October 27, 2014 – WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, for the treatment of patients with Epidermal Growth Factor Receptor (EGFR) mutation-negative, and Anaplastic Lymphoma […]

Pooled analysis of ASCEND and two CAPACITY phase III trials show 48 percent reduction in mortality risk at one year1 ASCEND data reinforces the Esbriet safety and efficacy profile1 Approximately 110,000 people in Europe have idiopathic pulmonary fibrosis (IPF), an irreversible, progressive, fatal lung disease2- 5 Only 20–40 percent of IPF patients survive five years […]

Investments of 3 billion Swiss francs in modern research infrastructure, attractive workplaces and sustainable site development Basel, 22 October 2014 – Today Roche presented development plans for its Basel site. Over the next 10 years, Roche will invest 3 billion Swiss francs in the construction of a new research and development centre for around 1,900 employees, […]

Paris, France – 20 October 2014 – GE Healthcare has been chosen by the Medical Imaging Antilles-Guyane (IMAG) purchasing group in France to lead a consortium providing a new cloud imaging platform which will allow vastly improved collaboration between clinicians in Martinique, Guadeloupe and French Guyana. The clinicians will be able to share diagnostic images […]

Biologics License Application (BLA) for secukinumab, a “first-in-class” IL-17A inhibitor, is currently under FDA review with an anticipated action date in early 2015 FDA Advisory Committee recommendation based on efficacy and safety outcomes of 10 Phase II/III clinical studies of secukinumab in moderate-to-severe plaque psoriasis Affecting 7.5 million Americans, psoriasis may negatively impact daily life […]

Phase III clinical study data presented at IDWeek in Philadelphia October 20, 2014 – WHITEHOUSE STATION, N.J. & SWIFTWATER, Pa.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:SAN and NYSE:SNY), announced today that the Biologics License Application (BLA) filed for the companies’ investigational […]